{"id":8153,"date":"2015-05-26T00:00:00","date_gmt":"2015-05-25T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2015\/05\/26\/la-braquiterapia-assoleix-una-curacio-del-95-en-el-cancer-de-prostata-de-baix-risc-cancer-de-prostata-de-baix-risc-seguiment-de-700-pacients\/"},"modified":"2020-05-13T19:47:37","modified_gmt":"2020-05-13T17:47:37","slug":"la-braquiterapia-assoleix-una-curacio-del-95-en-el-cancer-de-prostata-de-baix-risc-cancer-de-prostata-de-baix-risc-seguiment-de-700-pacients","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2015\/05\/la-braquiterapia-assoleix-una-curacio-del-95-en-el-cancer-de-prostata-de-baix-risc-cancer-de-prostata-de-baix-risc-seguiment-de-700-pacients\/","title":{"rendered":"La braquiter\u00e0pia assoleix una curaci\u00f3 del 95% en el c\u00e0ncer de pr\u00f2stata de baix risc C\u00e0ncer de pr\u00f2stata de baix risc Seguiment de 700 pacients"},"content":{"rendered":"<p><strong>Un <\/strong><strong>estudi publicat a <em>Brachytherapy<\/em> mostra els bons resultats d&#8217;aquesta t\u00e8cnica en aquest tipus de tumor<\/strong> El c\u00e0ncer de pr\u00f2stata \u00e9s el m\u00e9s freq\u00fcent en els homes a Catalunya. Se\u2019n donen uns 5.000 casos nous cada any, per sobre del de c\u00f2lon i recte (prop de 4.000 casos) i el de pulm\u00f3 (3.500). \u00c9s un c\u00e0ncer molt associat a l\u2019edat. L\u2019envelliment de la poblaci\u00f3 fa que la seva incid\u00e8ncia augmenti cada any. Segons les projeccions del Pla Director d\u2019Oncologia, l\u2019any 2020 se\u2019n produiran uns 6.000 casos nous anuals. <\/p>\n<p> Malgrat l\u2019elevada incid\u00e8ncia, \u00e9s un tumor de lenta evoluci\u00f3 en la majoria de casos, amb una superviv\u00e8ncia del 84% als cinc anys, tamb\u00e9 segons les dades del Pla Director d\u2019Oncologia. <\/p>\n<p> Molts pacients presenten un c\u00e0ncer de pr\u00f2stata de baix risc, \u00e9s a dir, les c\u00e8l\u00b7lules cancer\u00edgenes estan confinades a aquest \u00f2rgan i no s\u2019han disseminat, els nivells d\u2019antigen prost\u00e0tic espec\u00edfic (PSA) s\u00f3n inferiors a 10 i la puntuaci\u00f3 de Gleason \u00e9s inferior o igual a 6 (aquesta escala mesura el grau de malignitat de les c\u00e8l\u00b7lules). <\/p>\n<p> En aquests casos, hi ha quatre possibles alternatives: <\/p>\n<p> -Vigil\u00e0ncia activa (fer revisions peri\u00f2diques sense intervenir) <\/p>\n<p> -Cirurgia (extirpaci\u00f3 de la pr\u00f2stata o d\u2019una part) <\/p>\n<p> -Radioter\u00e0pia externa <\/p>\n<p> -Braquiter\u00e0pia <\/p>\n<p> El tractament amb braquiter\u00e0pia consisteix en la col\u00b7locaci\u00f3 d\u2019una font radioactiva \u2013en aquest cas en forma de llavors de iode-125\u2013 dintre o en la proximitat del tumor; la radiaci\u00f3 que emeten destrueix les c\u00e8l\u00b7lules malignes. Aquesta intervenci\u00f3 quir\u00fargica es fa una sola vegada durant el tractament. <\/p>\n<p> Diversos estudis han demostrat que la braquiter\u00e0pia \u00e9s la t\u00e8cnica que comporta menys efectes secundaris (generalment disfunci\u00f3 urin\u00e0ria i\/o sexual). <\/p>\n<p> L\u2019estudi que s\u2019ha presentat mostra els resultats de superviv\u00e8ncia de 700 pacients de c\u00e0ncer de pr\u00f2stata de baix risc sotmesos a braquiter\u00e0pia. El treball conclou que la curaci\u00f3 (\u00e9s a dir, el control bioqu\u00edmic) als cinc anys \u00e9s del 95% i, als deu anys, la superviv\u00e8ncia per causa espec\u00edfica (\u00e9s a dir, excloent les morts per altres causes) \u00e9s del 97%. Aix\u00ed mateix, s\u2019ha observat que els efectes secundaris s\u00f3n m\u00ednims.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un estudi publicat a Brachytherapy mostra els bons resultats d&#8217;aquesta t\u00e8cnica en aquest tipus de tumor<\/p>\n","protected":false},"author":6,"featured_media":10894,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8153","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"publishpress_future_action":{"enabled":false,"date":"2024-11-29 23:53:16","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=8153"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8153\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10894"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=8153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=8153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=8153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}